Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J O Rinne

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Acta Neurologica Scandinavica. Supplementum|January 1, 1991
Nigral degeneration in Parkinson's disease in relation to clinical featuresJ O Rinne
Annals of Medicine|February 19, 2000
Drug development for neurodegenerative diseases: role of PETJ O Rinne
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1993
Nigral degeneration in Parkinson's diseaseJ O Rinne
Brain Research|February 24, 1987
Muscarinic and dopaminergic receptors in the aging human brainJ O Rinne
Neurology|November 1, 1989
Treatment of early Parkinson's disease with controlled-release levodopa preparationsU K Rinne, J O Rinne
Neuropsychologia|May 1, 1996
Perceptual priming in Alzheimer's and Parkinson's diseasesM Koivisto, R Portin, J O Rinne
Journal of Clinical and Experimental Neuropsychology|February 1, 1997
Picture naming deficits in vascular dementia and Alzheimer's diseaseM Laine, E Vuorinen, J O Rinne
Brain Research|February 5, 1990
Age-dependent decline in human brain dopamine D1 and D2 receptorsJ O Rinne, P Lönnberg, P Marjamäki
Brain Research|October 8, 1993
Human brain methionine- and leucine-enkephalins and their receptors during ageingJ O Rinne, P Lönnberg, P Marjamäki
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 3, 2011
Amyloid imaging as a surrogate marker in clinical trials in Alzheimer's diseaseNoora M Scheinin, Mika Scheinin, J O Rinne
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Acta Neurologica Scandinavica. Supplementum|January 1, 1991
Nigral degeneration in Parkinson's disease in relation to clinical featuresJ O Rinne
Annals of Medicine|February 19, 2000
Drug development for neurodegenerative diseases: role of PETJ O Rinne
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1993
Nigral degeneration in Parkinson's diseaseJ O Rinne
Brain Research|February 24, 1987
Muscarinic and dopaminergic receptors in the aging human brainJ O Rinne
Neurology|November 1, 1989
Treatment of early Parkinson's disease with controlled-release levodopa preparationsU K Rinne, J O Rinne
Neuropsychologia|May 1, 1996
Perceptual priming in Alzheimer's and Parkinson's diseasesM Koivisto, R Portin, J O Rinne
Journal of Clinical and Experimental Neuropsychology|February 1, 1997
Picture naming deficits in vascular dementia and Alzheimer's diseaseM Laine, E Vuorinen, J O Rinne
Brain Research|February 5, 1990
Age-dependent decline in human brain dopamine D1 and D2 receptorsJ O Rinne, P Lönnberg, P Marjamäki
Brain Research|October 8, 1993
Human brain methionine- and leucine-enkephalins and their receptors during ageingJ O Rinne, P Lönnberg, P Marjamäki
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 3, 2011
Amyloid imaging as a surrogate marker in clinical trials in Alzheimer's diseaseNoora M Scheinin, Mika Scheinin, J O Rinne
Pageof 16